Cervix Uteri – V9: 2021+
Primary Site | Histology | Year of Diagnosis |
---|---|---|
C530-C531, C538-C539 | 8000-8700, 8720-8790, 8980, 9110 | 2021-9998, 9999 |
Notes
8000-8700, 8720-8790, 8980, 9110 C530 Endocervix C531 Exocervix C538 Overlapping lesion of cervix C539 Cervix uteri **Note 1:** The following sources were used in the development of this schema * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Cervix Uteri, from the AJCC Cancer Staging System Version 9 (2020). Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** See the following schemas for the listed histologies * 8710-8714, 8800-8803, 8805, 8810-8814, 8816-8858, 8860-8900, 8902-8910, 8921-8941, 8951-8976, 8981-8990, 8992-9016, 9030-9043, 9045-9105, 9111, 9121-9132, 9135-9138, 9141-9175, 9181-9221, 9230, 9240-9365, 9370-9580, 9582: *Cervix Sarcoma* * 8804, 8806, 8815, 8859, 8891, 8901, 8912, 8920, 9020, 9044, 9120, 9133, 9180, 9222, 9231, 9366-9368, 9581: *Soft Tissue Rare* * 8950: *Soft Tissue Abdomen and Thoracic* * 8992: *Soft Tissue Other* * 9140: *Kaposi Sarcoma* * 9700-9701: *Mycosis Fungoides*Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | Yes |
NAACCR #390
dateOfDiagnosis |
None | |
Primary Site | <BLANK> | Yes |
NAACCR #400
primarySite |
None | |
Histology | <BLANK> | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | |
Behavior | <BLANK> | Yes |
NAACCR #523
behaviorCodeIcdO3 |
None | |
Tumor Size Clinical | <BLANK> | No |
NAACCR #752
tumorSizeClinical |
None | |
Tumor Size Pathological | <BLANK> | No |
NAACCR #754
tumorSizePathologic |
None | |
Tumor Size Summary | 999 | Yes |
NAACCR #756
tumorSizeSummary |
None | |
Regional Nodes Positive | 99 | No |
NAACCR #820
regionalNodesPositive |
None | |
Regional Nodes Examined | 99 | No |
NAACCR #830
regionalNodesExamined |
None | |
LVI | 9 | No |
NAACCR #1182
lymphVascularInvasion |
None | |
RX Summ Surgery/Radiation Sequence | <BLANK> | No |
NAACCR #1380
rxSummSurgRadSeq |
None | |
RX Summ Systemic/Surgery Sequence | <BLANK> | No |
NAACCR #1639
rxSummSystemicSurSeq |
None | |
EOD Primary Tumor | 999 | Yes |
NAACCR #772
eodPrimaryTumor |
None | |
EOD Regional Nodes | 999 | Yes |
NAACCR #774
eodRegionalNodes |
None | |
EOD Mets | 00 | Yes |
NAACCR #776
eodMets |
None | |
SS2018 | <BLANK> | No |
NAACCR #764
summaryStage2018 |
None | |
Grade Clinical | 9 | No |
NAACCR #3843
gradeClinical |
CCCR/Canada COC NPCR SEER |
SSDI |
Grade Pathological | 9 | No |
NAACCR #3844
gradePathological |
CCCR/Canada COC NPCR SEER |
SSDI |
Grade Post Therapy Clin (yc) | <BLANK> | No |
NAACCR #1068
gradePostTherapyClin |
COC NPCR SEER |
SSDI |
Grade Post Therapy Path (yp) | <BLANK> | No |
NAACCR #3845
gradePostTherapy |
CCCR/Canada COC NPCR SEER |
SSDI |
FIGO Stage | 98 | No |
NAACCR #3836
figoStage |
COC SEER |
SSDI |
p16 | 8 | No |
NAACCR #3956
p16 |
COC 2021– NPCR 2022– SEER 2023– SEER (RC) 2021–2022 |
SSDI 2021– |
LN Status: Para-aortic | 8 | No |
NAACCR #3958
lnStatusParaAortic |
COC SEER |
SSDI |
Lymph Nodes Assessment Method Para-aortic | 8 | No |
NAACCR #3872
lnAssessMethodParaaortic |
COC SEER (RC) |
SSDI |
LN Status: Pelvic | 8 | No |
NAACCR #3957
lnStatusPelvic |
COC SEER |
SSDI |
Lymph Nodes Assessment Method Pelvic | 8 | No |
NAACCR #3873
lnAssessMethodPelvic |
COC SEER (RC) |
SSDI |
Lymph Nodes Distant: Mediastinal, Scalene | 8 | No |
NAACCR #3875
lnDistantMediastinalScalene |
COC SEER (RC) |
SSDI |
Lymph Nodes Distant Assessment Method | 8 | No |
NAACCR #3874
lnDistantAssessMethod |
COC SEER (RC) |
SSDI |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Schema ID | 09520 |
NAACCR #3800
schemaId |
None | |
Derived Version | {{ctx_alg_version}} | None | None | |
Derived Summary Stage 2018 | 9 |
NAACCR #762
derivedSummaryStage2018 |
None |